The Wegovy 0.5mg dose: what happens at this stage of treatment

Where does 0.5mg sit in the Wegovy dose schedule?

Wegovy's licensed dosing pathway runs in roughly four-week steps: 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, and finally 2.4mg as the maintenance dose. The first pen exists to help your system adjust; the 0.5mg pen is the first upward move. For many people, this is the stage where appetite suppression starts to feel tangible, meals feel filling sooner, and the urge to snack between them often quietly fades.

It is worth being clear that 0.5mg is still a titration dose. The clinical trials underpinning Wegovy's UK licence, including STEP 1, published in the New England Journal of Medicine, built up to a 2.4mg maintenance dose over 16 weeks. Most of the weight-loss benefit accumulates at those higher doses. That does not make 0.5mg a formality (it is genuinely doing something) but it is a step on the way rather than a destination. You can read more about how the full schedule works on our Wegovy dosing guide.

Your prescriber decides whether you move up on time or hold at 0.5mg for a little longer, and our page covering Wegovy doses explains what each stage of the schedule involves. Side effects, personal circumstances, and how well you're tolerating the current dose all feed into that call. The schedule is a framework, not a fixed rule.

What does 0.5mg of semaglutide actually do in the body?

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases naturally after eating; it signals to the brain that you've had enough, and it slows the rate at which your stomach empties. Semaglutide mimics that signal continuously rather than just after meals, which is why appetite can feel genuinely different rather than something you're fighting against.

At 0.5mg you are still in the lower range of the dose-response curve, and if you want to understand exactly how the Wegovy pen dose is set and delivered at this stage, the NHS semaglutide medicines page describes this mechanism clearly alongside what to expect at each stage of treatment. Blood-sugar regulation and gastric emptying both respond, but the full appetite-suppressing effect seen at 2.4mg has not yet been reached. The NHS semaglutide medicines page describes this mechanism clearly alongside what to expect at each stage of treatment.

One practical detail worth knowing: your pen lives in the fridge, ideally somewhere convenient like the door shelf, so the weekly injection becomes a routine rather than a hunt. If you are curious about how many injections your current pen contains, our guide to the Wegovy 4 dose pen covers exactly that. You can inject from the abdomen, thigh or upper arm; rotating sites helps avoid localised skin reactions. For the exact storage window at room temperature (useful if you're travelling) always check the Patient Information Leaflet included with your pen.

Are side effects worse when you move from 0.25mg to 0.5mg?

Dose increases are the most common trigger for GLP-1-related side effects, so it is honest to say that the step up to 0.5mg is a moment to pay attention. Nausea, loose stools, constipation and reflux are the most frequently reported reactions. They tend to peak in the first few days after the new dose and settle within one to two weeks for most people, though that is not a guarantee, and experiences vary.

Eating smaller portions, staying well hydrated, and avoiding rich or fatty meals can all help. None of this is about willpower; it is straightforward physiology. A slower gastric emptying rate means large meals sit heavily.

The MHRA's guidance on GLP-1 medicines includes a specific note on pancreatitis: severe, persistent abdominal pain that spreads to the back, with or without vomiting, warrants prompt medical attention. This is uncommon, but it is the kind of symptom not to sit on. If you are unsure about anything you're experiencing, our support team is available seven days a week, and you can report suspected side effects directly at the MHRA's Yellow Card scheme.

Can you stay at 0.5mg if the next dose feels too much?

Yes. Staying at a dose for longer than four weeks is a legitimate clinical choice, not a failure. Some people find the step to 1.0mg brings a noticeable increase in nausea, and if you want detail on what that next increment involves, our page on Wegovy 0.5mg covers the specifics of this part of the schedule. The licensed schedule provides a framework; it does not oblige you to rush through it.

There is a separate question of whether staying at 0.5mg indefinitely is sensible for weight management. The honest answer is that the evidence for long-term weight loss was built at 2.4mg. Holding at a lower dose for clinical reasons is reasonable; treating 0.5mg as a permanent level when you could safely progress is a conversation worth having with your prescriber. Our page on staying on the same Wegovy dose goes into that distinction in more detail.

If you are mid-treatment and thinking about whether Wegovy is the right option for you, or wondering how it compares to other licensed weight-loss treatments, those are exactly the questions our prescribers work through with you. A free consultation is the right place to start.